Morbidity of Solid Cancer in Behçet’s Disease: Analysis of 11 Cases in a Series of 506 Patients
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Behçet’s disease (BD) is rarely reported to be associated with malignancies in the literature. However, the frequency of cancer in BD patients remains unknown. This study evaluated cancer morbidity in BD patients compared with that in the general population of Korea. Materials and Methods: A retrospective chart review was performed on 506 patients visiting our hospital from 1994 to 2011 for BD. We analyzed the standardized morbidity rate (SMR), which is the ratio of observed to expected malignancies. Furthermore, we reviewed cases of solid cancer in BD patients in the literature. Results: Of the 506 patients with BD, 11 (2.17%) developed cancer. We found a variety of solid cancers without predominance and no hematologic malignancies. The total number of cancers observed was less than expected, which was determined from the statistical data of the National Cancer Information Center of Korea, with an SMR of 0.023 (95% confidence interval, 0.012-0.039). Conclusion: BD may be associated with a lower cancer-related morbidity compared with the general population of Korea.
Abstract
Purpose: Behçet’s disease (BD) is rarely reported to be associated with malignancies in the literature. However, the frequency of cancer in BD patients remains unknown. This study evaluated cancer morbidity in BD patients compared with that in the general population of Korea. Materials and Methods: A retrospective chart review was performed on 506 patients visiting our hospital from 1994 to 2011 for BD. We analyzed the standardized morbidity rate (SMR), which is the ratio of observed to expected malignancies. Furthermore, we reviewed cases of solid cancer in BD patients in the literature. Results: Of the 506 patients with BD, 11 (2.17%) developed cancer. We found a variety of solid cancers without predominance and no hematologic malignancies. The total number of cancers observed was less than expected, which was determined from the statistical data of the National Cancer Information Center of Korea, with an SMR of 0.023 (95% confidence interval, 0.012-0.039). Conclusion: BD may be associated with a lower cancer-related morbidity compared with the general population of Korea.
참고문헌 (42)
- Sakane T, "Behçet’s disease", N Engl J Med, 341, pp.1284~1291 (1999)
- Direskeneli H, "Autoimmunity vs autoinflammation in Behcet’s disease: do we oversimplify a complex disorder?", Rheumatology, 45, pp.1461~1465 (2006)
- Pankhurst T, "Malignancy is increased in ANCA-associated vasculitis", Rheumatology, 43, pp.1532~1535 (2004)
- Szekanecz Z, "Malignancies in autoimmune rheumatic diseases - a mini-review", Gerontology, 57, pp.3~10 (2011)
- Liang JA, "Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study", Rheumatol Int, 32, pp.773~778 (2012)
- Abu-Shakra M, "Cancer in systemic sclerosis", Arthritis Rheum, 36, pp.460~464 (1993)
- So MW, "Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis", J Rheumatol, 38, pp.2432~2435 (2011)
- Kaklamani VG, "Behçet’s disease associated with malignancies. Report of two cases and review of the literature", Clin Exp Rheumatol, 23(4), pp.S35~S41 (2005)
- Criteria for diagnosis of Behçet’s disease, "International Study Group for Behçet’s Disease", Lancet, 335, pp.1078~1080 (1990)
- Mizushima Y, "Revised diagnostic criteria for Behçet’s disease in 1987", Ryumachi, 28, pp.66~70 (1988)
- Tagami H, "Unusual case of malignant pharyngeal granuloma--with symptoms resembling Behcet’s syndrome", Hifuka Kiyo, 65, pp.253~261 (1970)
- Tamaoki N, "Thymic change in Behçet’s disease", Keio J Med, 21, pp.201~213 (1972)
- Hamza MH, "Cancer complicating Behçet’s disease treated with chlorambucil", Ann Rheum Dis, 45, pp.789~ (1986)
- Kamata T, "A case report of the development of intestinal Behcet disease immediately after sigmoidectomy for sigmoid cancer", Jpn J Gastroenterol Surg, 21, pp.2331~2334 (1988)
- Oishi S, "Pheochromocytoma associated with Behçet’s disease", Jpn J Clin Oncol, 19, pp.283~286 (1989)
- Murata I, "A case of Behçet disease associated with hepatocellular carcinoma", Gan No Rinsho, 35, pp.625~631 (1989)
- Muramatsu M, "The development of malignant rhabdoid tumor in a patient with Behçet’s disease treated with ciclosporin", Graefes Arch Clin Exp Ophthalmol, 236, pp.798~799 (1998)
- Bethea L, "Behçet’s disease and pheochromocytoma", J S C Med Assoc, pp.295~298 (1999)
- Celik I, "Cyclophosphamide-associated carcinoma of the urinary bladder in Behçet’s disease", Nephron, 81, pp.239~ (1999)
- Akpolat T, "Small-cell carcinoma as a cause of superior vena cava syndrome in a patient with Behçet’s disease", Respiration, 67, pp.593~ (2000)
- Kötter I, "HHV8 associated Kaposi’s sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet’s disease and complete remission of both disorders with interferon alpha", Ann Rheum Dis, 60, pp.83~86 (2001)
- Baltaci S, "Invasive bladder carcinoma in a patient with Behçet’s disease", Int J Urol, 10, pp.669~671 (2003)
- Nishimura K, "A case of hilar bile duct cancer with intestinal Behçet’s disease", Kurume Med J, 51, pp.169~173 (2004)
- Satolli F, "Merkel-cell carcinoma in Behçet’s disease", Acta Derm Venereol, 85, pp.79~ (2005)
- 권기민, "베체트병 환자에서 발생된 간내 및 복부 피하조직 전이를 동반한 간의 원발성 평활근육종 1예", Clinical and Molecular Hepatology, 11(2005), pp.386~391 (2005), 대한간학회
- Lee JE, "Colon Cancer in Behcet’s Disease", Yeungnam Univ J Med, 23, pp.124~130 (2006)
- Kammori M, "The pathological findings of vasculitis simultaneously occurring with carcinoma, invasive breast carcinoma in a patient with Behçet’s disease", Breast Cancer, 13, pp.378~381 (2006)
- Mezalek ZT, "Kaposi’s sarcoma in association with Behcet’s disease: case report and literature review", Semin Arthritis Rheum, 36, pp.328~331 (2007)
- Meyer J, "Formation of a bronchoesophageal fistula following concurrent radiation and chemotherapy for lung cancer in the setting of Behçet’s disease", J Thorac Oncol, 3, pp.1361~1362 (2008)
- Chargari C, "Severe acute radiation-related skin toxicity in a breast cancer patient with Behçet’s disease", Radiother Oncol, 91, pp.139~ (2009)
- Yamada M, "Colon cancer arising in an ulcer scar due to intestinal Behçet’s disease", Intern Med, 50, pp.429~432 (2011)
- Ahn JK, "Behcet’s disease associated with malignancy in Korea: a single center experience", Rheumatol Int, 30, pp.831~835 (2010)
- Cengiz M, "Malignancy in Behçet’s disease: a report of 13 cases and a review of the literature", Clin Rheumatol, 20, pp.239~244 (2001)
- Shahram F, "Behcet’s disease and malignancy, report of 11 cases, In Behcet’s disease", pp.515~519 (2000), Design Mecca Publishing Co.
- Kural-Seyahi E, "The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center", Medicine, 82, pp.60~76 (2003)
- Bang D, "Ten Cases of Behcet’s disease associated with Tumor, In Behcet’s disease", pp.526~528 (2000), Design Mecca Publishing Co
- Rubin DC, "Chronic intestinal inflammation:inflammatory bowel disease and colitis-associated colon cancer", Front Immunol, 3, pp.107~ (2012)
- Lioté F, "Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection", J Rheumatol, 22, pp.1174~1178 (1995)
- Harada M, "A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis", Hepatol Res, 31, pp.116~119 (2005)
- Chen MR, "Epstein-barr virus, the immune system, and associated diseases", Front Microbiol, 2, pp.5~ (2011)
- Zandman-Goddard G, "Infections and SLE", Autoimmunity, 38, pp.473~485 (2005)
- Kaklamani VG, "Role of polymorphisms in Adamantiades-Behçet’s disease", J Rheumatol, 35, pp.2376~2378 (2008)
